Business Description
Affymax Inc
NAICS : 325412
SIC : 2834
ISIN : US00826A1097
Description
Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.
Financial Strength
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 7.91 | |||||
9-Day RSI | 21.61 | |||||
14-Day RSI | 31.3 | |||||
12-1 Month Momentum % | -83.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -19919.05 |
GF Value Rank
Name | Current | Vs Industry | Vs History |
---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AFFY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Affymax Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.042 | ||
EPS (TTM) ($) | 0.06 | ||
Beta | 10.4 | ||
Volatility % | 331.59 | ||
14-Day RSI | 31.3 | ||
14-Day ATR ($) | 0.000028 | ||
20-Day SMA ($) | 0.0007 | ||
12-1 Month Momentum % | -83.33 | ||
52-Week Range ($) | 0.0002 - 0.0407 | ||
Shares Outstanding (Mil) | 37.49 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Affymax Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Affymax Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Affymax Inc Frequently Asked Questions
What is Affymax Inc(AFFY)'s stock price today?
The current price of AFFY is $0.00. The 52 week high of AFFY is $0.04 and 52 week low is $0.00.
When is next earnings date of Affymax Inc(AFFY)?
The next earnings date of Affymax Inc(AFFY) is .
Does Affymax Inc(AFFY) pay dividends? If so, how much?
Affymax Inc(AFFY) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |